[Problems in drug therapy of hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D001581:Benzothiadiazines; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006145:Guanethidine / Q000627:therapeutic use; D006439:Hemodynamics; D006591:Hexobarbital / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001581:Benzothiadiazines; D002301:Cardiac Glycosides; D002395:Catecholamines; D004232:Diuretics; D010276:Parasympatholytics; D049993:Sodium Chloride Symporter Inhibitors; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D006591:Hexobarbital; D006145:Guanethidine
Nekotorye problemy medikamentoznogo lecheniia gipertonicheskoĭ bolezni